U.S. Semiconductors Stock News

Key Insights Using the 2 Stage Free Cash Flow to Equity, Spectral AI fair value estimate is US$2.14 Current share price...

Crexendo (NASDAQ:CXDO) has had a great run on the share market with its stock up by a significant 14% over the last...

Key Insights Institutions' substantial holdings in Ouster implies that they have significant influence over the...

CRH plc ( NYSE:CRH ) saw a decent share price growth of 10% on the NYSE over the last few months. The company's trading...

We wouldn't blame Medpace Holdings, Inc. ( NASDAQ:MEDP ) shareholders if they were a little worried about the fact that...

Some Bunge Global SA ( NYSE:BG ) shareholders may be a little concerned to see that the Executive Vice President of...

Cullinan Therapeutics has started a rolling submission with the FDA for accelerated approval of zipalertinib, its experimental drug for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. This regulatory step follows positive results from the Phase 1/2 REZILIENT1 trial and builds on the drug’s prior Breakthrough Therapy Designation. See our latest analysis for Cullinan Therapeutics. The momentum around Cullinan Therapeutics has turned noticeably positive this month,...

On November 18, 2025, Interface, Inc. delivered a notice of conditional redemption for all of its US$300,000,000 outstanding principal amount of 5.50% Senior Notes due 2028, with a redemption date set for December 3, 2025, subject to the satisfaction of a financing condition. This move highlights Interface's focus on proactive debt management and signals potential adjustments to its capital structure and financial strategy. We will explore how Interface’s conditional debt redemption and...

Wondering if ExlService Holdings is offering genuine value or hiding risks beneath the surface? You are not alone—many investors are closely examining the numbers for answers. The stock has slipped 14.1% over the last year. Interestingly, it has gained 3.3% in the past month, which may indicate renewed optimism or changing perceptions in the market. Recent headlines have focused on ExlService Holdings' strategic shifts and new client partnerships. These developments are fueling speculation...

Wondering if Ingram Micro Holding could be a bargain right now? You are not alone, as investors continue to scout for undervalued opportunities in a rapidly changing tech sector. Ingram Micro Holding’s stock has seen some movement lately, rising 3.6% in the last week but dipping 2.9% over the last month. This hints at shifting sentiment and the potential for both growth and caution. Market attention has sharpened following industry updates about global supply chain improvements and renewed...

DiDi Global (OTCPK:DIDI.Y) just posted its Q3 2025 results, reporting revenue of ¥58.6 billion and basic EPS of ¥0.31. Looking at recent trends, revenue has moved from ¥53.0 billion in Q4 2024, to ¥53.3 billion in Q1 2025, to ¥56.4 billion in Q2 2025, and now to the latest ¥58.6 billion reported. Net income also saw a swing, landing at ¥1.5 billion this quarter after being in the red last period. Despite not turning a full-year profit yet, these numbers suggest margins are showing signs of...

Alto Ingredients, Inc. recently announced that Jeremy T. Bezdek resigned from its Board of Directors to become president and CEO at The Lifetime Group, effective November 24, 2025. This leadership transition comes alongside a significant third-quarter earnings beat for Alto Ingredients, highlighting both executive change and operational progress. We'll explore how the combination of a board departure and recent financial outperformance could influence Alto Ingredients' investment...

If you have ever wondered whether Life Time Group Holdings is really worth its current price, you are not alone. We are about to break down what the market might be getting right or missing entirely. The stock has climbed 12.4% over the past week and is up a solid 24.6% year-to-date, suggesting investors are warming up to its growth story or seeing reduced risks on the horizon. Recently, the company's inclusion in new fitness industry partnerships and media coverage of expanding club...

Ever wondered if Fortive's current share price is a bargain or a trap? You're not alone. We're about to unpack what really matters for investors looking for value. After a rough start to the year, Fortive has seen its stock bounce back with a 5.6% rise over the past week and a 7.6% gain in the past month, even as the year-to-date return remains sharply negative at -28.5%. These price swings have come on the back of expanded M&A activity in the industrial tech sector, with speculation...

Curious if Dole is a hidden value play or just another produce stock? You are not alone, and we are digging into the facts to find out if now is the right time to pay attention. Dole shares have perked up lately, jumping 5.3% in the past week and 12.3% over the last month. This signals that the market is paying fresh attention to the stock, even though it is down just under 2% over the past year. Several recent headlines have focused on the company’s role in evolving food sustainability...

Ambarella (AMBA) just posted its Q3 2026 results, reporting $108.5 million in revenue and basic EPS of -$0.35 as net losses continued. Looking back, the company has seen revenue trend from $63.7 million in Q2 2025 up to $108.5 million this quarter, while EPS has remained negative throughout. Margins remain under pressure, making profitability the key question on investors’ minds this quarter. See our full analysis for Ambarella. Now, let's put these results to the test and see how they match...

Li Auto (NasdaqGS:LI) just posted its Q3 2025 numbers, reporting revenue of ¥27.4 billion and a basic EPS of -¥0.62. Over recent quarters, the company has seen revenue shift from ¥31.7 billion in Q2 2024 to ¥44.3 billion in Q4 2024, then back to ¥27.4 billion in the most recent period, with corresponding swings in EPS. While overall growth drivers remain in focus, investors are weighing these results against compressed profit margins, which continue to influence sentiment around the...

Wondering if Mach Natural Resources stock is a bargain or about to break out? You are not alone, and getting the value right can make all the difference. The stock has seen some ups and downs lately, dropping 4.4% over the last week and sliding 6.6% in the past month. These moves often signal either growing opportunity or increased risk. One big reason for the recent changes has been the ripple effect of sector-wide energy news and shifting market sentiment toward oil and gas companies...

Curious whether Federal Signal is a hidden bargain or fully priced after its impressive rally? You are definitely not alone in wanting to understand where the value lies in this popular industrial stock. Shares have surged 5.1% in the last week and remain up 22.3% year-to-date, but they did drop 10.0% over the past month, signaling both rapid growth and shifting investor sentiment. Much of the recent excitement follows Federal Signal's strategic expansion moves, including several...

Aurinia Pharmaceuticals (AUPH) shares have been steadily gaining ground this month. This trend reflects investor optimism around the company’s performance in the autoimmune therapeutics space. Recent trading shows a positive momentum for the stock. See our latest analysis for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' 1-month share price return of 33.2% is part of an even stronger year-to-date rally, with shares climbing 86.66%. The stock’s 1-year total shareholder return stands at...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Preformed Line Products fair value estimate is US$186...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Pony AI (PONY) has just reported Q3 2025 results, posting revenue of $25.4 million and a basic EPS of -$0.16. Over recent quarters, the company’s revenue has moved from $14.0 million in Q1 2025, to $21.5 million in Q2, reaching $25.4 million in the latest period, while EPS has remained negative. Despite consistent revenue gains, margins are still challenged as losses persist, keeping profitability in focus for investors. See our full analysis for Pony AI. Now, let’s see how these reported...

Despite a 36% gain in Pacific Biosciences of California, Inc.'s ( NASDAQ:PACB ) stock price this week, shareholders...